Family studies in melanoma: Identification of the atypical mole syndrome (AMS) phenotype

Melanoma Research

Volumn 4, Issue 4, 1994, Pages 199-206

  Bishop, J A Newton ^a   Bataille, V ^a   Pinney, E ^a   Bishop, D T ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Genetics; Melanocytic naavi; Melanoma

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENETICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; FEMALE; HUMAN; MALE; MELANOMA; NEVUS; PEDIGREE; PHENOTYPE; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0028095067     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/00008390-199408000-00001     Document Type: Article

References (31)

1. Norris W. A case of fungoid disease. Edinburgh Med Surg J 1820; 16: 562-565.
2. Traboulsi EI, Zimmerman LE, Manz HJ. Cutaneous malignant melanoma in survivors of heritable retinoblastoma. Arch Ophthalmol 1988; 106: 1059-1061.
3. Tucker MA, Strong LC, Li F, et al. Retinoblastoma (RB) and the dysplastic nevus syndrome (DNS): association with second primary cancers (SC), including cutaneous malignant melanoma (CMM), abstracted. Proc 72nd Annual Meeting Am Assoc Cancer Res. Baltimore: Waverly Press, 1981: 405.
4. Draper GJ, Sanders BM, Kingston JE. Second primary neoplasms in patients with retinoblastoma. Br J Cancer 1986; 53: 661-671.
5. Little JB, Nove J, Dahlberg WK, et al. Normal cytotoxic response of skin fibroblasts from patients with Li-Fraumeni familial cancer syndrome to DNA-damaging agents in vitro. Cancer Res 1987; 47: 4229-4234.
6. Lynch HT, Watson P, Kriegler M, et al. Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II). Dis Colon Rectum 1988; 31: 372-377.
7. National Institutes of Health Consensus Development Conference Statement. January 1992.
8. Clark WM, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from hereditable melanocytic lesions: the ‘BK mole syndrome’, Arch Dermatol 1978; 114: 732.
9. Crutcher WA. The dysplastic nevus and its clinical management. Adv Dermatol 1988; 3: 187-204.
10. Rodriguez-Sains RS. Ocular findings in patients with dysplastic nevus syndrome. Ophthalmology 1986; 93: 661-665.
11. Clark WH, Ackerman AB. An exchange of views regarding the dysplastic nevus controversy. Semin Dermatol 1989; 8: 229-250.
12. Ahmed I, Piepkorn MW, Rabkin MS, et al. Histopathologic characteristics of dysplastic nevi. Limited association of conventional histologic criteria with melanoma risk group. J Am Acad Dermatol 1990; 22: 727-733.
13. Bale SJ, Dracopoli NC, Tucker MA, et al. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus syndrome to chromosome lp. New Engl JMed 1989; 320: 1367-1372.
14. Cooke KR, Spears GFS, Elder DE, et al. Dysplastic naevi in a population-based survey. Cancer 1989; 63: 1240-1244.
15. Crutcher WA, Sagebiel RW. Prevalence of dysplastic naevi in a community practice. Lancet 1984; 1: 729.
16. Stierner U, Augustsson A, Rosdahl I, et al. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study. Melanoma Res 1990; 1: 367-375.
17. Elder DE. Dysplastic nevi. Their significance and management. Dermatol Clin 1988; 6: 257-269.
18. Cook MG, Fallowfield ME. Dysplastic naevi—an alternative view. Histopathology 1990; 16: 29-35.
19. Bergman W, Palan A, Went LN. Clinical and genetic studies in six Dutch kindreds with the dysplastic naevus syndrome. Ann Hum Genet 1986; 50: 249-258.
20. Cannon-Albright LA, Goldgar DE, Wright EC, et al. Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome lp36. Am J Hum Genet 1990; 46: 912-918.
21. Goldgar DE, Cannon-Albright LA, Meyer LJ, et al. Inheritance of nevus number and size in melanoma/DNS kindreds. Cytogenet Cell Genet 1992; 59: 200-202.
22. Cannon-Albright LA, Goldgar DE, Meyer LJ, et al. Assignment of a locus for familial melanoma MLM, to chromosome 9 p13-p22. Science 1992; 258: 1148-1152.
23. Mackie R. Multiple melanoma and atypical melanocytic naevi—evidence of an activated and expanded melanocytic system. Br J Dermatol 1992; 107: 521-529.
24. Newton JA. Familial melanoma—a review. Clin Exp Dermatol 1993; 18: 5-11.
25. Newton JA, Bataille V, Griffiths K, etal. How common is the atypical mole syndrome in apparently sporadic melanoma? J Am Acad Dermatol 1993; 29: 989-996.
26. Office Population Census and Statistics. Cancer Statistics: Registrations 1985. Series MB1 No. 18 Published 1990, London: Her Majesty's Stationery Office.
27. Roberts DL. Malignant melanoma in West Glamorgan: increasing incidence and improving prognosis 1986-1988. Clin Exp Dermatol 1990; 15: 406-409.
28. Bishop DT, Thomas H. The genetics of colorectal cancer. Cancer Sum 1990; 9. 585-604.
29. Osterlind A, Tucker MA, Stone BJ, et al. The Danish case-control study of cutaneous melanoma. II Importance of UV-light exposure. Int J Cancer 1988; 42: 319-324.
30. Swerdlow AJ. Epidemiology of cutaneous malignant melanoma. Clin Oncol 1984; 3: 407-437.
31. Khlat M, Vail A, Parkin M, et al. Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay. Am J Epidemiol 1992; 135: 1103-1113.